1 Magnificent S&P 500 Dividend Stock Down 56% to Buy and Hold Forever
Given its key role in the fight against COVID-19, the fact that (NYSE: PFE) shares are down 56% from their 2021 peak isn't entirely surprising. Demand for its COVID-19 vaccine (Comirnaty) and its treatment (Paxlovid) soared during the pandemic's height. With the coronavirus contagion abating in the meantime, though, last year's sales fell 41%. Income fell more than 70% year over year. Yikes.
However, the stock's sellers have arguably overshot their target. Pfizer stock is not only now well undervalued, but it's now sporting a big dividend yield of 6.2% as well.
That's a well-funded dividend, by the way, that's been raised every year for the past 15 years.
Source Fool.com
Pfizer Inc. Aktie
27,74 €
-2,38 %
Die Community bevorzugt Pfizer Inc., mit deutlich mehr Buy- (29) als Sell-Einschätzungen (4).
Ein Kursziel von 41 € für Pfizer Inc. würde eine Steigerung von mehr als 20% gegenüber dem aktuellen Kurs von 27.74 € bedeuten.
